Why RNAZ? TransCode Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
RNAZ
$7.74-0.32 (-3.97%)
TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.